Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase

The crystal structure of human liver glyceraldehyde-3-­phosphate dehydrogenase (GAPDH) has been determined. This structure represents the first moderate-resolution (2.5 Å) and crystallographically refined (R_free = 22.9%) human GAPDH structure. The liver GAPDH structure consists of a homotetramer, each subunit of which is bound to a nicotinamide adenine dinucleotide (NAD⁺) molecule. The GAPDH enzyme has glycolytic and non-glycolytic functions, both of which are of chemotherapeutic interest. The availability of a high-quality human GAPDH structure is a necessity for structure-based drug design. In this study, structural differences between human liver and skeletal muscle GAPDHs are reported in order to understand how these two enzymes might respond to anti-trypanosomatid GAPDH inhibitors.